Different Generations of Type-B Monoamine Oxidase Inhibitors in Parkinson’s Disease: From Bench to Bedside

Three inhibitors of type-B monoamine oxidase (MAOB), selegiline, rasagiline, and safinamide, are used for the treatment of Parkinson’s disease (PD). All three drugs improve motor signs of PD, and are effective in reducing motor fluc-tuations in patients undergoing long-term L-DOPA treatment. The eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Alborghetti, Marika, Nicoletti, Ferdinando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052841/
https://www.ncbi.nlm.nih.gov/pubmed/30160213
http://dx.doi.org/10.2174/1570159X16666180830100754

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052841/
https://www.ncbi.nlm.nih.gov/pubmed/30160213
http://dx.doi.org/10.2174/1570159X16666180830100754

Ejemplares similares